Supplemental material
Drug Delivery
Volume 26, 2019 - Issue 1
Research Article
Improved drug targeting to liver tumor by sorafenib-loaded folate-decorated bovine serum albumin nanoparticles
, , , , , , , & 
show all
Baogang XieDepartment of Infectious Diseases, The Second Affiliated Hospital of Nanchang University, School of Pharmaceutical Science, Nanchang University, NanchangPR ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-0685-1346View further author information
https://orcid.org/0000-0002-0685-1346View further author information show allRelated Research Data
Folate-decorated anticancer drug and magnetic nanoparticles encapsulated polymeric carrier for liver cancer therapeutics.
Source:
Elsevier BV
Folate-mediated delivery of macromolecular anticancer therapeutic agents
Source:
Elsevier BV
Combination Trans Arterial Chemoembolization (TACE) Plus Sorafenib for the Management of Unresectable Hepatocellular Carcinoma: A Systematic Review of the Literature
Source:
Springer Science and Business Media LLC
Tumour-selective drug delivery via folate receptor-targeted liposomes
Source:
Informa Healthcare
Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro
Source:
Informa UK Limited
Protein nanoparticles as drug carriers in clinical medicine.
Source:
Elsevier BV
Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
Source:
Elsevier BV
Treatment of advanced hepatocellular carcinoma with emphasis on hepatic arterial infusion chemotherapy and molecular targeted therapy.
Source:
S. Karger AG
Folate-conjugated beta-cyclodextrin-based polymeric micelles with enhanced doxorubicin antitumor efficacy
Source:
Elsevier BV
Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine
Source:
Elsevier BV
Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301
Source:
American Society of Clinical Oncology (ASCO)
A quantitative HPLC-UV method for determination of serum sorafenib and sorafenib N-oxide and its application in hepatocarcinoma patients.
Source:
Tohoku University Medical Press
Targeted drug delivery via the folate receptor.
Source:
Elsevier BV
Attachment of an anti-MUC1 monoclonal antibody to 5-FU loaded BSA nanoparticles for active targeting of breast cancer cells
Source:
IOS Press
Linking provided by
